Welltower Inc. (WELL)
| Market Cap | 145.88B +46.7% |
| Revenue (ttm) | 11.77B +37.6% |
| Net Income | 1.41B +30.0% |
| EPS | 2.05 +18.3% |
| Shares Out | 705.91M |
| PE Ratio | 101.04 |
| Forward PE | 76.70 |
| Dividend | $2.96 (1.43%) |
| Ex-Dividend Date | May 13, 2026 |
| Volume | 8,060,846 |
| Open | 208.52 |
| Previous Close | 206.55 |
| Day's Range | 202.90 - 208.52 |
| 52-Week Range | 148.97 - 221.68 |
| Beta | 0.78 |
| Analysts | Buy |
| Price Target | 235.48 (+13.95%) |
| Earnings Date | Jul 27, 2026 |
About WELL
Welltower Inc. is a S&P 500 company, is positioned at the center of the silver economy, focusing on rental housing for aging seniors across the United States, United Kingdom and Canada. Our portfolio of 2,000+ seniors and wellness housing communities are positioned at the intersection of housing and hospitality, creating vibrant communities for mature renters and older adults. We believe our real estate portfolio is unmatched, located in highly attractive micro markets with stunning built environments. Yet, we are an unusual real estate organiz... [Read more]
Financial Performance
In 2025, Welltower's revenue was $10.84 billion, an increase of 35.63% compared to the previous year's $7.99 billion. Earnings were $936.85 million, a decrease of -1.56%.
Financial StatementsAnalyst Summary
According to 21 analysts, the average rating for WELL stock is "Buy." The 12-month stock price target is $235.48, which is an increase of 13.95% from the latest price.
News
Welltower price target lowered to $232 from $248 at Scotiabank
Scotiabank lowered the firm’s price target on Welltower (WELL) to $232 from $248 and keeps an Outperform rating on the shares. The firm sees real estate investment trust valuations as…
WELL Health Announces Voting Results for Election of Directors
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impa...
Welltower resumed with an Outperform at Raymond James
Raymond James analyst David Rodgers resumed coverage of Welltower (WELL) with an Outperform rating and $226 price target The firm sees investor focus shifting from Welltower’s from investments to its…
WELL Health Provides a Corporate Update on Circle Medical
WELL Health is providing a corporate update on its majority-owned subsidiary Circle Medical, a leading telehealth platform delivering accessible, insurance-based primary care across the United States....
Ecolab added to ‘US 1 List’ at BofA
BofA added Ecolab (ECL) to the firm’s “US 1 List,” a collection of its best investment ideas. The firm is also renewing Nvidia (NVDA) and Welltower (WELL) after 52 weeks…
Welltower raises quarterly dividend 15% to 85c per share
Welltower (WELL) announced that it expects to raise its quarterly common stock dividend to 85c per share, beginning with the second quarter of 2026. The declaration and payment of any…
Welltower Board of Directors Approves 15% Increase in Quarterly Dividend to $0.85 per Share
TOLEDO, Ohio, June 1, 2026 /PRNewswire/ -- Welltower Inc. (NYSE: WELL) ("Welltower" or the "Company") today announced that it expects to raise its quarterly common stock dividend to $0.85 per share, b...
FrontView REIT Appoints Welltower Co-President and CFO Tim McHugh to Board of Directors
DALLAS--(BUSINESS WIRE)--FrontView REIT, Inc. (NYSE: FVR) (the “Company,” “FrontView,” “we,” “our,” or “us”) today announced the appointment of Timothy G. “Tim” McHugh to the Company's Board of Direct...
Welltower price target raised to $277 from $260 at BofA
BofA raised the firm’s price target on Welltower (WELL) to $277 from $260 and keeps a Buy rating on the shares after updating models for Q1 earnings from the healthcare…
Welltower Transcript: AGM 2026
The meeting covered board introductions, voting on director elections, auditor ratification, and executive compensation. All directors and the auditor were approved, but the advisory vote on executive compensation did not pass. Shareholder questions will be addressed online.
Welltower price target raised to $248 from $236 at Scotiabank
Scotiabank raised the firm’s price target on Welltower (WELL) to $248 from $236 and keeps an Outperform rating on the shares. The firm is updating its price targets for U.S.
Welltower price target raised to $248 from $237 at Jefferies
Jefferies analyst Jonathan Petersen raised the firm’s price target on Welltower (WELL) to $248 from $237 and keeps a Buy rating on the shares. The firm adjusted estimates after the…
Welltower price target raised to $255 from $245 at Citi
Citi raised the firm’s price target on Welltower (WELL) to $255 from $245 and keeps a Buy rating on the shares.
Welltower price target raised to $245 from $240 at BMO Capital
BMO Capital raised the firm’s price target on Welltower (WELL) to $245 from $240 and keeps an Outperform rating on the shares as part of a broader research note on…
Welltower price target raised to $238 from $230 at RBC Capital
RBC Capital raised the firm’s price target on Welltower (WELL) to $238 from $230 and keeps an Outperform rating on the shares after its Q1 earnings beat and guidance raise.
Welltower price target raised to $249 from $240 at UBS
UBS raised the firm’s price target on Welltower (WELL) to $249 from $240 and keeps a Buy rating on the shares. The key takeaway from the Q1 earnings is that…
Welltower Earnings Call Transcript: Q1 2026
Revenue and EBITDA surged over 35% year-over-year, with record same-store NOI growth and strong margin expansion. Updated guidance reflects continued momentum, robust investment activity, and a focus on high-quality seniors housing assets, supported by digital transformation and disciplined capital allocation.
Welltower Earnings release: Q1 2026
Welltower released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.
Welltower Slides: Q1 2026
Welltower has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
Welltower Quarterly report: Q1 2026
Welltower has published its Q1 2026 quarterly earnings report on April 29, 2026.
Welltower raises FY26 normalized FFO view to $6.21-$6.35 from $6.09-$6.25
Consensus is for FY26 FFO $6.22. Sees FY26 average blended SSNOI growth of 12.25%-16.00%, which is comprised of the following components: Seniors Housing Operating approximately 16.5%-21.5%; Seniors H...
Welltower reports Q1 normalized FFO $1.47, consensus $1.45
Reports Q1 revenue $3.35B, consensus $3.2B. Reports Q2 total portfolio year-over-year SSNOI growth of 16.4%, driven by SSNOI growth in our Seniors Housing Operating portfolio of 22.1%. Published first...
Welltower Issues Business Update
TOLEDO, Ohio, April 28, 2026 /PRNewswire/ -- Welltower® Inc. (NYSE: WELL) has issued the following business update which can be found at: https://welltower.com/apr-28-26-business-update About Welltow...
Welltower Reports First Quarter 2026 Results
TOLEDO, Ohio, April 28, 2026 /PRNewswire/ -- Welltower Inc. (NYSE:WELL) today announced results for the quarter ended March 31, 2026. First Quarter and Other Recent Highlights Reported net income attr...